
Since its first description in human beings in 1986, ehrlichiosis is now increasingly recognized as a cause of tick-borne febrile illnesses. However, the disease has been reported only rarely in immunosuppressed patients. We report a case of human ehrlichiosis in a patient with a cadaveric renal transplant. The diagnosis was confirmed initially by a positive polymerase chain reaction (PCR) for E. chaffeensis. The antibody titer became positive several weeks later. The patient responded promptly to treatment with doxycycline. Ehrlichiosis should be considered in the differential diagnosis of an acute febrile illness in transplant recipients. PCR provides a rapid means to confirm the diagnosis, particularly in settings in which antibody response may be suppressed.
Adult, DNA, Bacterial, Immunosuppression Therapy, Male, Ehrlichiosis, Antibodies, Bacterial, Kidney Transplantation, Polymerase Chain Reaction, Anti-Bacterial Agents, Diagnosis, Differential, Ehrlichia chaffeensis, Injections, Intravenous, Humans, Drug Therapy, Combination
Adult, DNA, Bacterial, Immunosuppression Therapy, Male, Ehrlichiosis, Antibodies, Bacterial, Kidney Transplantation, Polymerase Chain Reaction, Anti-Bacterial Agents, Diagnosis, Differential, Ehrlichia chaffeensis, Injections, Intravenous, Humans, Drug Therapy, Combination
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 26 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
